Here’s Why IDEXX Laboratories (IDXX) Shares are Re-Rating to Historical Average

4 weeks ago 22

Soumya Eswaran

Fri, February 20, 2026 astatine 8:14 AM CST 2 min read

Conestoga Capital Advisors, an plus absorption company, released its fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap Strategy returned -5.75% nett of fees compared to the Russell Midcap Growth Index’s -3.70% return. The underperformance was driven by antagonistic banal enactment successful the Technology and Industrials sectors, portion affirmative assemblage allocation effects partially eased underperformance. The Mid Cap Composite returned -4.73% nett of fees for the afloat twelvemonth 2025, trailing the benchmark instrumentality of 8.66%. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Conestoga Capital Advisors highlighted stocks specified arsenic IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) is simply a US-based healthcare institution that manufactures products for the companion carnal veterinary, livestock and poultry, dairy, and h2o investigating industries. On February 19, 2026, IDEXX Laboratories, Inc. (NASDAQ:IDXX) banal closed astatine $630.73 per share. IDEXX Laboratories, Inc. (NASDAQ:IDXX) delivered a -9.10% instrumentality successful the past month, and its shares gained 39.30% implicit the past 12 months. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has a marketplace capitalization of $50.461 billion.

Conestoga Capital Advisors stated the pursuing regarding IDEXX Laboratories, Inc. (NASDAQ:IDXX) successful its 4th fourth 2025 capitalist letter:

"IDEXX Laboratories, Inc. (NASDAQ:IDXX) is the manufacture person successful providing instruments (and consumables) utilized successful diagnostics, detection, and accusation systems for veterinary, food, and h2o investigating applications. IDXX continued its inclination of net beats and continued to amusement resilient integrated gross maturation successful the look of anemic veterinary postulation trends. Shares continued to re-rate backmost to mean humanities valuation."

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 55 hedge money portfolios held IDEXX Laboratories, Inc. (NASDAQ:IDXX) astatine the extremity of the 3rd quarter, up from 48 successful the erstwhile quarter. While we admit the imaginable of IDEXX Laboratories, Inc. (NASDAQ:IDXX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article